spacer
home > news > detailed info
INDUSTRY NEWS AND PRESS RELEASES

TP3 Global receives Royal recognition by winning the Queen’s Awards for Enterprise 2018

TP3 Global


Birmingham, UK, 23 April 2018 – TP3 Global, a leading global innovator and provider of thermal protection for temperature sensitive cargo, is pleased to announce it has been awarded the 2018 Queen’s Awards for Enterprise in the International Trade category for its globally-recognised Silverskin™ brand.

The Queen’s Awards for Enterprise are the United Kingdom’s most prominent business awards, which commend enterprise excellence. TP3 Global won the recognition for outstanding growth in overseas sales over the past three years. SilverSkinTM has become a major brand in the market, recognised, approved and used by the leading pharmaceutical companies around the world. TP3 Global has seen rapid growth thanks to a strong focus on providing consistent quality and innovative solutions to a worldwide client base.

Clive Wheeldon, President of TP3 Global, commented: “We are extremely proud to achieve the prestigious Queen’s Award for Enterprise for international trade. Our commitment to providing market-leading products, innovation and high-quality customer service has resulted in working with the industry’s leading pharmaceutical companies.

 “We continue to invest heavily in R&D, global footprint and customer service ensuring we stay at the forefront of the market. We are delighted to see many of the world’s pharmaceutical companies utilise SilverskinTM to maintain the integrity of their products in their supply chain. Our team is very proud to have won a prestigious Queen’s Award that recognises our on-going commitment to innovation and excellence for international trade.”

 The Queen’s Awards for Enterprise first began in 1966. They are awarded to businesses for outstanding achievement in four categories International Trade, Innovation, Sustainable Development and also for Promoting Opportunity (through social mobility).



phone 01962 435006
email lisa@amplify-pr.co.uk
web www.tp3global.com
 
Print this page
Send to a friend
   
spacer
News and Press Releases

PCI Pharma Services Announces Agreement to Acquire Sherpa Clinical Packaging

Philadelphia, USA – September 10, 2018 Leading global biopharmaceutical outsourcing services provider PCI Pharma Services (PCI) is pleased to announce the acquisition of San Diego-based Sherpa Clinical Packaging (Sherpa), which expands PCI’s U.S. operations to the West Coast. The acquisition of Sherpa, a provider of clinical trial supply services, further strengthens PCI’s position as a leader in outsourced clinical trial support services. The addition of Sherpa’s capabilities also enables PCI to better support customers from early phases of clinical development through to commercial launch.
More info >>


White Papers

Is Your Biobank Ready for the Challenge of Biomarker-based Research?

BioFortis

Targeted and personalized studies with well-defined patient segmentation biomarkers are becoming the norm in clinical trials. This increased interest in molecular biomarker studies necessitates a rigor and sophistication in sample management within the clinical trial context that is often not supported either by traditional clinical trial management software (CTMS), or biobanking systems.  Download our Next Generation Biobanking whitepaper and learn about how to overcome the key challenges in clinical trial sample management from working in a distributed network of partners and stakeholder to managing consents and generating scientific insights.
More info >>

Industry Events

Pre-Filled Syringes & Injectable Drug Devices Europe

16-17 January 2019, Copthorne Tara Hotel, London

SMi is proud to present their 11th annual European conference and exhibition, within the Pre-Filled Syringes series: Pre-Filled Syringes & Injectable Drug Devices Europe. The event will take place on the 16th-17th of January 2019, in London.
More info >>

 
©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement